Philips Smart Quant Neuro 3D MR imaging AI application.

Philips and SyntheticMR develop AI software to support neurological assessment

March 07, 2024
by John R. Fischer, Senior Reporter
Philips, in collaboration with AI software developer SyntheticMR, has developed a decision-support tool for diagnosis and treatment planning of brain diseases such as multiple sclerosis (MS), traumatic brain injury (TBI), dementia, and more.

The solution, Smart Quant Neuro 3D, makes recommendations based on automated quantitative measurements taken of various brain tissues to assess brain disease and progression. It can also be used to monitor the effects of therapy to suggest necessary adjustments in treatment, or form objective assessments of and differentiate traumatic brain injuries from other neurological conditions.

Smart Quant Neuro 3D utilizes Philips' AI-based SmartSpeed image-reconstruction technology, Philips 3D SyntAc clinical application, and SyntheticMR's SyMRI NEURO 3D quantitative tissue assessment software. These separate components together enable it to:
"Smart Quant Neuro 3D allows for shorter exams and exploration of quantitative metrics, which show great potential to better stratify patients with similar imaging characteristics on conventional MR sequences. It's a fast quantitative MR technique that's integrated into our clinical workflow, allowing us to generate multiple synthetic weighted images from a single sequence," said Dr. Julien Savatovsky, neuroradiologist and head of the radiology department at the Hospital Foundation Adolphe De Rothschild in Paris, France, in a statement.